Systemic exposure to cisplatin and paclitaxel after intraperitoneal chemotherapy in ovarian cancer. de Jong LAW, Lambert M, van Erp NP, de Vries L, et al. Cancer Chemother Pharmacol 2023 Mar 9. doi: 10.1007/s00280-023-04512.

Read + Share

Amedeo Smart

Independent Medical Education

de Jong LAW, Lambert M, van Erp NP, de Vries L, et al. Systemic exposure to cisplatin and paclitaxel after intraperitoneal chemotherapy in ovarian cancer. Cancer Chemother Pharmacol 2023 Mar 9. doi: 10.1007/s00280-023-04512.
PMID: 36892677